The patient was referred to a heart failure cardiologist who also specializes in PH, who prescribed empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, to treat the patient's HFpEF. This evidence concerns the gene SLC5A2 and heart failure.